A compound having the structure wherein Y is selected from the group consisting of —C(O)OR
2
, —C(O)NHR
8
, —C(CH
2
)
1-2
OR3, OH, and or a pharmaceutically acceptable salt thereof, and methods of using the compounds for treating hypertension.
[EN] NITROOXY CYCLOALKANE DERIVATIVES<br/>[FR] DÉRIVÉS DE NITROOXY CYCLOALCANE
申请人:MERCK SHARP & DOHME
公开号:WO2010062415A1
公开(公告)日:2010-06-03
A compound having the structure wherein Y is selected from the group consisting of –C(O)OR2, -C(O)NHR8, -C(CH2)1-2OR3, OH, and or a pharmaceutically acceptable salt thereof, and methods of using the compounds for treating hypertension.